Kelvin K. Lee

724 total citations
8 papers, 545 citations indexed

About

Kelvin K. Lee is a scholar working on Pathology and Forensic Medicine, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kelvin K. Lee has authored 8 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Epidemiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kelvin K. Lee's work include Substance Abuse Treatment and Outcomes (3 papers), Alcohol Consumption and Health Effects (3 papers) and Oral and gingival health research (1 paper). Kelvin K. Lee is often cited by papers focused on Substance Abuse Treatment and Outcomes (3 papers), Alcohol Consumption and Health Effects (3 papers) and Oral and gingival health research (1 paper). Kelvin K. Lee collaborates with scholars based in United States and Japan. Kelvin K. Lee's co-authors include Richard K. Fuller, D. Blöch, Helena C. Kraemer, Kenneth E. James, Enoch Gordis, Roy B. Lacoursiere, Dennis R. Brightwell, L. Branchey, Chad D. Emrick and K James and has published in prestigious journals such as CHEST Journal, Statistics in Medicine and Journal of Periodontology.

In The Last Decade

Kelvin K. Lee

8 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelvin K. Lee United States 6 183 130 76 66 64 8 545
James W. Keating United Kingdom 12 50 0.3× 72 0.6× 63 0.8× 5 0.1× 41 0.6× 28 563
Mauricio Jadzinsky Argentina 13 77 0.4× 27 0.2× 112 1.5× 29 0.4× 40 0.6× 23 1.2k
Sean P. Riley United States 14 171 0.9× 56 0.4× 138 1.8× 14 0.2× 17 0.3× 46 871
Stephan R. Weinland United States 15 36 0.2× 53 0.4× 132 1.7× 54 0.8× 11 0.2× 25 827
Chryssa Pourzitaki Greece 13 86 0.5× 30 0.2× 55 0.7× 11 0.2× 59 0.9× 58 645
Rodrigo O. Moreira Brazil 22 182 1.0× 29 0.2× 138 1.8× 73 1.1× 13 0.2× 60 1.2k
John Cooney Ireland 10 73 0.4× 41 0.3× 45 0.6× 13 0.2× 17 0.3× 27 554
Kitty Lawrence Austria 10 34 0.2× 28 0.2× 111 1.5× 15 0.2× 17 0.3× 16 403
T. H. Caradoc‐Davies New Zealand 11 75 0.4× 52 0.4× 32 0.4× 4 0.1× 36 0.6× 21 467

Countries citing papers authored by Kelvin K. Lee

Since Specialization
Citations

This map shows the geographic impact of Kelvin K. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelvin K. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelvin K. Lee more than expected).

Fields of papers citing papers by Kelvin K. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelvin K. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelvin K. Lee. The network helps show where Kelvin K. Lee may publish in the future.

Co-authorship network of co-authors of Kelvin K. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Kelvin K. Lee. A scholar is included among the top collaborators of Kelvin K. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelvin K. Lee. Kelvin K. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
James, Kenneth E., D. Blöch, Kelvin K. Lee, Helena C. Kraemer, & Richard K. Fuller. (1996). AN INDEX FOR ASSESSING BLINDNESS IN A MULTI-CENTRE CLINICAL TRIAL: DISULFIRAM FOR ALCOHOL CESSATION—A VA COOPERATIVE STUDY. Statistics in Medicine. 15(13). 1421–1434. 194 indexed citations
2.
Nery, Edmundo B., et al.. (1995). Prevalence of Nifedipine‐Induced Gingival Hyperplasia. Journal of Periodontology. 66(7). 572–578. 71 indexed citations
3.
Fuller, Richard K., Kelvin K. Lee, & Enoch Gordis. (1988). Validity of Self‐Report in Alcoholism Research: Results of a Veterans Administration Cooperative Study. Alcoholism Clinical and Experimental Research. 12(2). 201–205. 93 indexed citations
4.
Fuller, Richard K., L. Branchey, Dennis R. Brightwell, et al.. (1986). Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.. PubMed. 256(11). 1449–55. 150 indexed citations
5.
Simon, Michael R., Kelvin K. Lee, Kenneth E. James, et al.. (1986). Method for the Derivation of Clinical and Laboratory Indices in Relation to Disease Activity and Outcome in Sarcoidosis. CHEST Journal. 89(1). 138–140. 1 indexed citations
6.
Young, Larry M., et al.. (1984). Riboflavin use as a drug marker in Veterans Administration Cooperative Studies. Controlled Clinical Trials. 5(4). 497–504. 16 indexed citations
7.
Fuller, Richard K., et al.. (1984). Veterans administration cooperative study of disulfiram in the treatment of alcoholism: Study design and methodological considerations. Controlled Clinical Trials. 5(3). 263–273. 16 indexed citations
8.
Steer, Arthur, et al.. (1977). Small Cardiac Lesions. Japanese Heart Journal. 18(6). 812–822. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026